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Figure 6. Color Doppler image obtained 4 months and one week postoperatively, confirming stent patency and normal flow in the
anterior segmental branch. The posterior branch was occluded.
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Maleux et al ’ JVIR918 ’ Letters to the Editorof fresh frozen plasma over 4 days. Aspirin therapy was
begun after the seventh postoperative day at 150 mg/d.
On day 15 postoperatively, Doppler ultrasound and
computed tomography angiography revealed occlusion
of the posterior segmental branch of the hepatic artery,
with normal flow in the main graft artery and its anterior
branch. There were also areas of congestion in segments
V and VIII and a 5-cm infarct in segment VI.
Initial postoperative graft dysfunction occurred with
marked elevation in aminotransferase and bilirubin
levels: alanine aminotransferase, 2,844 IU/L; aspartate
aminotransferase, 4,736 IU/L; and bilirubin, 22.5 mg/
dL. The elevated transferase returned to normal levels
and bilirubin reached 2 mg/dL 3 weeks postoperatively.
The graft dysfunction was attributed to early venous
congestion, possible ischemic injury from prolonged
surgery, and compromise of the posterior branch of the
graft artery later on. The patient was discharged from
the intensive care unit 25 days postoperatively. Addi-
tional anastomotic biliary leakage was managed by
failed endoscopic stent placement, then hepaticojejunost-
omy on postoperative day 52. The patient was dis-
charged from the hospital on postoperative day 82.
At the 4-month and 1-week postoperative follow-up
examination, the stent and the anterior branch of the
graft artery were patent with normal flow (Fig 6), and
the posterior branch remained occluded. There was
liquefaction in the infarct without signs of infection, and
expected segmental biliary strictures had not yet developed.
Our experience of 550 LDLTs includes endovascular
intervention in 16 patients with early postoperative
hepatic artery thrombosis. We believe that angio-
plasty and stent placement of a fresh hepatic arteryanastomosis carries a high risk of complications, includ-
ing spasm, further dissection, and perforation, which are
common in the first 48 hours postoperatively. Although
the long-term patency of the stent remains in question in
our case, with comorbidities including coagulopathy,
there was an emergent need to salvage the graft. We also
had the advantage of open surgical backup.
In conclusion, hybrid surgical reconstruction of the
hepatic artery and endovascular stent placement is
possible and effective for graft salvage in LDLT. Proper
tailoring of antiplatelet therapy is crucial in the perio-
perative period to ensure long-term stent patency.REFERENCE
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Aortic endograft thrombotic occlusion after endovascu-
lar aortic repair (EVAR) is uncommon, with an inci-
dence between 0 and 7%, and mostly occurs within the
first 2 months after EVAR. We encountered three
patients with progressive formation of a floating throm-
bus in the right iliac limb of a new-generation modular
stent graft (Endurant; Medtronic, Minneapolis, Minne-
sota), occurring at different time intervals after initial
EVAR. Institutional review board approval was waived
for these case reports.
In the first case, a 60-year-old man presented with a
55-mm-diameter asymptomatic infrarenal abdominal
aortic aneurysm (AAA) and was treated endovascularly
with an Endurant modular aortic stent graft. After the
procedure, the patient was prescribed lifelong acetylsa-
licylic acid at a daily dosage of 80 mg. Follow-up
computed tomography (CT) scans performed at 6 and
12 months after initial EVAR revealed a small, focal,
floating thrombus at the distal end of the right iliac stent
graft limb. Clinically, the patient was symptom-free, and
a strict regimen of antiplatelet therapy was continued.
The patient developed right-sided intermittent claudica-
tion 18 months after EVAR, which was associated with
distal migration of the growing floating thrombus into
the deep and superficial femoral artery. It was decided
to treat the patient’s claudication conservatively by
adding coumarins to the antiplatelet drug regimen for
12 months. At 30 months after EVAR, CT scan re-
vealed a formation of new thrombotic material in
the right limb of the stent graft, which was managedFigure. (a) Axial CT scan performed 6 months after EVAR reveals
Corresponding coronal CT reconstruction shows the floating thrombu
CT scan performed 2 years after relining with an e-PTFE-covered Exclu
the right relined stent graft limb (arrowheads).by relining the right limb of the stent graft with a 24-mm
distal diameter Dacron-based limb extension (Endurant
contralateral limb and limb extension; Medtronic). CT
scan performed 1 year later after relining the right limb
revealed a newly formed floating thrombus in the relined
right stent graft limb. It was decided to treat the clot
formation by relining the right limb a second time with
the use of an expanded polytetrafluoroethylene (e-PTFE)
stent graft limb with a nominal diameter of 27 mm
(GORE EXCLUDER limb; W. L. Gore & Associates,
Flagstaff, Arizona). Regular clinical and follow-up over
24 months showed absence of formation of thrombotic
deposits in the stent graft body or limbs.
In the second case, a 65-year-old man presented with
a 58-mm-diameter asymptomatic AAA, which was
successfully excluded with a Dacron-based modular
stent graft (Endurant). The postoperative course was
uneventful, and the patient was prescribed lifelong
acetylsalicylic acid at a daily dosage of 80 mg. On the
6-month follow-up CT scan, a floating thrombus was
identified in the right limb of the stent graft (Fig a, b).
The patient had no symptoms of claudication at that
time. It was decided to reline the right stent graft limb
with an e-PTFE covered stent graft limb (GORE
EXCLUDER limb) with a length of 95 mm and a distal
diameter of 20 mm. The patient recovered well without
residual symptoms. The patient presented 2 years after
the initial EVAR procedure with severe contralateral
(left-sided) claudication. Radiologic investigation
revealed an occluded left tibiofibular trunk, potentially
related to distal embolization. Abdominal CT scan could
not demonstrate thrombotic material within the body or
left limb of the stent graft. The patient was treated by
percutaneous recanalization and angioplasty of the
tibiofibular trunk; early recurrence of symptoms
occurred, and conservative management including exer-
cise therapy and continued antiplatelet therapy was
prescribed. Serial follow-up CT scans of the endograft
over a 2-year period did not reveal any newly formeda floating thrombus (arrow) in the right stent graft limb. (b)
s (arrows) in the distal part of the right stent graft limb. (c) Axial
der stent graft limb shows absence of any thrombotic material in
Maleux et al ’ JVIR920 ’ Letters to the Editorthrombotic deposits in the stent graft body or either of
the limbs (Fig c).
In the third case, a 58-year-old man presented with an
asymptomatic, 55-mm-diameter infrarenal AAA, which
was successfully excluded by endovascular techniques
using a modular Dacron-based stent graft (Endurant).
After the procedure, the patient was prescribed lifelong
acetylsalicylic acid at a daily dosage of 80 mg. CT scan
performed 2 years after EVAR revealed a stable aneur-
ysmal sac diameter, a discrete inflammatory layer
around the AAA, and a small newly formed floating
thrombus in the right limb of the stent graft. Follow-up
CT scan performed 6 months later showed clear growth
of the floating thrombus, although the patient remained
asymptomatic. At that time, it was decided to reline the
right limb of the stent graft with a 27-mm-distal-
diameter e-PTFE-covered stent graft limb (GORE
EXCLUDER limb). Follow-up CT scans performed
over 1.5 years did not reveal any recurrent clot forma-
tion in the stent graft limb, and clinically the patient is
doing well.
The presence of a floating thrombus in the thoracic
or abdominal aorta in general or in an aortic endograft
in particular is very rare. In a cohort of 496
patients treated with the Endurant stent graft, van
Zeggeren et al (1) identified two cases of floating
thrombus formation. These authors did not comment
on further treatment and outcome. The incidence of
asymptomatic circumferential thrombotic deposits in
endografts has been studied better, and these may
occur in 30% of cases (2); complete endograft limb
occlusion may occur in 1%–5% when using currently
available endografts (1,3). In patients treated with the
Endurant stent graft for infrarenal aortic aneurysms, the
incidence of complete thrombotic limb occlusion is
between 1% and 4% (1,4). Complete limb occlusion
most commonly occurs during the first 60 days after
stent graft insertion. In 60% of cases, a technical error
during the initial EVAR procedure was considered to be
the cause of the occlusion, including extreme stent graft
oversizing, positioning of the endograft limb in a kink of
the iliac vessel, performing the completion angiogram
without removing the stiff guide wire, overlooking
indications for balloon angioplasty distal to the stent
graft limb (1), or using a long small-diameter stent graft
landing in the external iliac artery (3). In the first and
third cases presented, the floating thrombus was
identified on a CT scan performed 2 years after
EVAR. In all three cases, a floating thrombus was
identified that was only partially occluding the stent
graft limb. None of the patients had other serious
comorbidities, including hemostatic disorders, or experi-
enced paraneoplastic or other cancer-related complica-
tions. Finally, we could not find any technical or anatomic
cause of clot formation because in all three cases the stentgraft was planned in accordance with current guidelines
and instructions for use. There was no limb kinking or
distal iliac stenosis, and the stent graft landed in a
relatively large and nontortuous common iliac artery.
Treatment of a floating thrombus within a stent graft
limb is challenging. In the first case, we initiated medical
anticoagulation treatment with coumarins; however, the
floating thrombus did not disappear, and distal emboli-
zation developed. Relining with another Endurant stent
graft limb was performed. The patient presented with a
newly formed floating thrombus in the relined limb 1
year after reintervention. At that time, large-bore e-
PTFE-covered stent graft limbs became available on the
market, and a GORE EXCLUDER stent graft limb
with a nominal diameter of 27 mm was used to reline the
Endurant stent graft limb a second time. This technique
of relining the Endurant limb with an e-PTFE-covered
EXCLUDER limb, completely trapping the floating
thrombus in between the two layers of the stent graft
limbs, seems very effective: Recurrent thrombus forma-
tion was not detected in any of the cases on serial follow-
up CT scans after 2, 2, and 1.5 years. The reason a
Dacron-based Endurant stent graft might rarely be
associated with a floating thrombus in an endograft
limb is unclear, although early experimental reports
suggested that e-PTFE is less thrombogenic than
Dacron-based grafts. It also was demonstrated that
circumferential clot formation occurs more frequently
in Dacron-based stent grafts compared with e-PTFE-
based stent grafts (3).
In conclusion, late formation of a floating thrombus in
an Endurant stent graft limb without clear technical,
anatomic, or biochemical predisposing factors for clot
formation may occur. This floating thrombus may be
resistant to medical and anticoagulation therapy and
may reappear after relining with another Dacron-based
stent graft limb. Conversely, relining with e-PTFE-
covered stent graft limbs might be a better and more
durable treatment option to manage a floating thrombus
in an Endurant stent graft limb, but longer follow-up in
more patients is needed to reach a definitive conclusion.REFERENCES
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